Reformulations Must Provide Added Value Genetic Engineering News The medication is used after organ transplant to prevent organ rejection, and it has been shown to provide a more favorable short-term clinical outcome and a lower incidence of rejection when compared to cyclosporine. Tacrolimus is the most commonly ... |
